FOXQ1 protein expression is significantly higher in triple-negative breast cancer samples than in normal mammary tissues, so it is a novel target of breast cancer stem cells’ inhibition by diallyl trisulfide (31). Here, FOXQ1 is linked to breast carcinoma.